Matt always was the stiff rudder in the BOT ship and thankfully after drifting with the ebbs and flows of the tide during his absense BOT is putting it together in a much more disciplined manner. Credibility has certainly been restored. Isn't it amazing that after waiting, moaning, groaning, wondering, pondering, meandering, but essentially hoping about the double edged sword that was Rosacea that one three minute read of an ASX announcement restores nine months of faith. To state one of dozens of stock market truisms, 'The markets are not terribly efficient in the short term but they are in the long term".
THE RETURN OF THE MATT !!!!
Ann: Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea, page-53
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.0¢ | $3.051M | 8.277M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 465836 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 301865 | 3 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |